Skip to search formSkip to main contentSkip to account menu

saliphenylhalamide

Known as: saliPhe 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AmidesSalicylates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Synthesis and structure-activity studies of the V-ATPase inhibitor saliphenylhalamide (SaliPhe) and simplified analogs.
Highly Cited
2013
Highly Cited
2013
Inhibition of influenza A virus infection in vitro by saliphenylhalamide-loaded porous silicon nanoparticles.
Influenza A viruses (IAVs) cause recurrent epidemics in humans, with serious threat of lethal worldwide pandemics. The occurrence… 
Highly Cited
2012
Highly Cited
2012
Prevention of Wear Particle-Induced Osteolysis by a Novel V-ATPase Inhibitor Saliphenylhalamide through Inhibition of Osteoclast Bone Resorption
Wear particle-induced peri-implant loosening (Aseptic prosthetic loosening) is one of the most common causes of total joint… 
Highly Cited
2011
Highly Cited
2011
The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections
BACKGROUND AND PURPOSE Cellular vacuolar ATPases (v‐ATPase) play an important role in endosomal acidification, a critical step in… 
2008
2008
Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)